Qube Research & Technologies (QRT)
ADMS

Qube Research & Technologies (QRT)’s Adamas Pharmaceuticals ADMS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,823
Closed -$112K – 2588
2020
Q4 		$112K Buy
25,823
+12,026
+87% +$51.5K ﹤0.01% 1629
2020
Q3 		$57K Sell
13,797
-10,812
-44% -$41.8K ﹤0.01% 1536
2020
Q2 		$63K Buy
+24,609
New +$72.3K ﹤0.01% 1569

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ADMS Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Adamas Pharmaceuticals (ADMS) in Q1 2021, closing a stake of 25,823 shares — an estimated $112K sold.

Qube Research & Technologies (QRT) first reported a position in ADMS in Q2 2020 and held it in 3 quarters. The position peaked at $112K in Q4 2020. 73 funds tracked by Wall St. Rank hold ADMS as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Adamas Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 25,823 Adamas Pharmaceuticals shares in Q1 2021, an estimated $112K.
  • Qube Research & Technologies (QRT) first reported a position in Adamas Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Adamas Pharmaceuticals position peaked at $112K in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.